Commercialisation
AgorIP is here to hopefully help you and your IP reach commercialisation
AgorIP is here to hopefully help you and your IP reach commercialisation
Find out more about what Intellectual Property means, and how we protect it
We have access to funding for specialist licensing and contracts managers
We can assist you with specialist market reports based on your innovation
Email Us
[email protected]
Follow Us:
Your AgorIP journey step-by-step
Thanks to EU and Welsh Government support, AgorIP can help you realise the potential of your idea, product or research. Our team of experts are here to help you take your intellectual property (IP) to the marketplace and help make it a commercial success.
Intellectual Property (IP) refers to creations of the mind- something unique that you physically create. An idea alone is not Intellectual Property. For example, an idea for a book doesn’t count, but the words you’ve written do.
Cross-Cutting Themes are issues which touch on general principles such as democracy, equality, sustainability, and good governance. They must be embedded into every EU-funded project. This will ensure that the benefits of the EU funds are shared inclusively by people and communities in Wales – improving both the quality and legacy of each EU project.
Of which 35% are from the Health & Social Care Sector
45 new jobs have been created since the beginning of AgorIP in 2016
Created 17 New companies
48 new products have gone to market
Secured over £1m private investment
This project will support the transformation of research with the potential for commercialisation in universities and health boards.
The Bevan Commission is delighted to be working with the AgorIP project.
Having experienced the evolution of AgorIP from its inception, I remain impressed with the quality of intellectual property coming through the programme.
Swansea University is doing very special things. Agor in Welsh means open and that is the feeling of the project and the academics in Swansea.
AgorIP is a great project. It fills a critical gap between scientific research and commercialisation.
